0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Nanoplastics Policy & Risk Sign in to save

Microplastics, nanoplastics, and plastic chemicals: applying the key characteristics of metabolism disrupting agents shows reason for concern

Environmental Endocrinology 2026 Score: 50 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Angel Nadal, Esther Fuentes, Jane Muncke, Sally Freels, Robert M Sargis

Summary

Researchers applied the key characteristics framework for metabolism-disrupting agents to evaluate plastic-derived chemicals and micro- and nanoplastic particles. The study suggests that common plastic chemicals such as perfluorinated compounds and plastic particles themselves meet criteria associated with metabolic disruption, raising concerns about their potential role in metabolic diseases.

Models

Abstract Objective This narrative review examines the potential role of plastic-derived chemicals and micro- and nanoplastics in metabolic diseases. It applies the recently proposed key characteristics (KCs) for metabolism-disrupting agents to evaluate chemicals commonly found in plastics and microplastic and nanoplastic particles. Methods The KC framework, adapted from the KCs of toxicants originally developed for the identification of carcinogens, was applied to evaluate evidence from epidemiological, animal, and cellular studies. The review specifically evaluates compounds such as perfluorooctanoic acid (PFOA), bisphenol-S (BPS), and diisonyl phthalate (DINP), as well as emerging evidence relating to microplastics and nanoplastics (MNPs). Results Evidence shows that exposure to chemicals derived from plastics, including PFOA, BPA substitutes (eg, BPS) and phthalate substitutes, is linked to metabolic dysfunction, obesity, diabetes, and MASLD. BPS and DINP exhibit properties consistent with metabolism-disrupting agents, suggesting they are “regrettable substitutes.” Although human data on MNPs are limited, animal and cellular studies indicate they may also contribute to metabolic diseases, though mechanisms remain unclear. Conclusion Rising exposure to chemicals in plastics poses significant risks to metabolic health. Identifying metabolic disruptors among thousands of plastic-associated chemicals is urgently needed. Increasing awareness and promoting the use of safer, inert, and reusable materials are essential steps to reduce health risks associated with plastic-derived pollutants and support more sustainable consumption.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics

This review examines how environmental chemicals, including contaminants associated with plastics, can disrupt human metabolism and contribute to conditions like obesity and diabetes. Researchers mapped the connections between chemical exposure and changes in metabolic biomarkers that signal disease risk. The study highlights the emerging field of metabolism-disrupting chemicals and the importance of understanding how everyday environmental exposures influence long-term metabolic health.

Article Tier 2

Microplastic pollution: A potent threat for metabolic disruption in mammals

This review examines the evidence linking microplastic exposure to metabolic disruption, covering mechanisms by which microplastics and their associated chemical additives may interfere with hormonal regulation, glucose metabolism, and lipid homeostasis. The authors identify microplastics as a potent emerging threat to metabolic health.

Review Tier 2

Cellular mechanisms of microplastic and nanoparticle exposure and its relationship with metabolic diseases: Literature review

This literature review examined how microplastic and nanoparticle exposure affects cellular mechanisms related to metabolic disease, finding evidence that these contaminants disrupt insulin signaling, alter lipid metabolism, and may contribute to the development of metabolic syndrome.

Article Tier 2

A metabolomics perspective on the effect of environmental micro and nanoplastics on living organisms: A review

This review examines how scientists use metabolomics, the study of small molecules produced by cellular processes, to understand the toxic effects of microplastics and nanoplastics on living organisms. The research shows that these plastic particles disrupt metabolism in consistent ways across species, affecting energy production, fat processing, and amino acid pathways. These shared metabolic disruptions across different organisms suggest that microplastics could cause similar metabolic problems in humans.

Article Tier 2

Eco-toxicity of nano-plastics and its implication on human metabolism: Current and future perspective

This review examines the sources, bioaccumulation pathways, and potential health effects of nanoplastics on human metabolism. Researchers found that nanoplastics can enter the body primarily through ingestion of contaminated food and packaging, and evidence suggests they may interfere with metabolic pathways and contribute to organ dysfunction. The study highlights that significant knowledge gaps remain in assessing the human health risks of nanoplastic exposure.

Share this paper